ATE209904T1 - Verfahren zur herstellung von pharmazeutischen zusammensetzungen durch die absetzung von arzenei/zyklodextrin komplexe auf inerte oder aktive kerne - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen durch die absetzung von arzenei/zyklodextrin komplexe auf inerte oder aktive kerne

Info

Publication number
ATE209904T1
ATE209904T1 AT95670004T AT95670004T ATE209904T1 AT E209904 T1 ATE209904 T1 AT E209904T1 AT 95670004 T AT95670004 T AT 95670004T AT 95670004 T AT95670004 T AT 95670004T AT E209904 T1 ATE209904 T1 AT E209904T1
Authority
AT
Austria
Prior art keywords
inert
drug
solution
pharmaceutical compositions
cyclodextrin
Prior art date
Application number
AT95670004T
Other languages
English (en)
Inventor
Sousa Goucha Jorge Pedro Ma De
Original Assignee
Tecnimede Sociedade Tecnico Medicinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8221680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE209904(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tecnimede Sociedade Tecnico Medicinal Sa filed Critical Tecnimede Sociedade Tecnico Medicinal Sa
Application granted granted Critical
Publication of ATE209904T1 publication Critical patent/ATE209904T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95670004T 1995-05-29 1995-05-29 Verfahren zur herstellung von pharmazeutischen zusammensetzungen durch die absetzung von arzenei/zyklodextrin komplexe auf inerte oder aktive kerne ATE209904T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95670004A EP0745381B1 (de) 1995-05-29 1995-05-29 Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen durch die Absetzung von Arzenei/Zyklodextrin Komplexe auf inerte oder aktive Kerne

Publications (1)

Publication Number Publication Date
ATE209904T1 true ATE209904T1 (de) 2001-12-15

Family

ID=8221680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95670004T ATE209904T1 (de) 1995-05-29 1995-05-29 Verfahren zur herstellung von pharmazeutischen zusammensetzungen durch die absetzung von arzenei/zyklodextrin komplexe auf inerte oder aktive kerne

Country Status (5)

Country Link
EP (1) EP0745381B1 (de)
AT (1) ATE209904T1 (de)
DE (1) DE69524393T2 (de)
ES (1) ES2169114T3 (de)
PT (1) PT745381E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061062A1 (en) * 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0241806A1 (de) * 1986-04-14 1987-10-21 Fujisawa Pharmaceutical Co., Ltd. Transdermale Zubereitungen mit verzögerter Freisetzung

Also Published As

Publication number Publication date
DE69524393D1 (de) 2002-01-17
PT745381E (pt) 2002-05-31
EP0745381B1 (de) 2001-12-05
EP0745381A1 (de) 1996-12-04
ES2169114T3 (es) 2002-07-01
DE69524393T2 (de) 2002-09-19

Similar Documents

Publication Publication Date Title
Yang et al. Anion effect on the nanostructure of a metal ion binding self-assembling peptide
ATE122698T1 (de) Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel.
ATE98964T1 (de) Zusammensetzungen welche komplexe von hyaluronsaeure enthalten und verfahren zu deren herstellung.
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
ATE191642T1 (de) Herstellung von proteinmikrospähren, filmen und beschichtungen
ATE217896T1 (de) Lösung von cellulose zur formung und verfahren zur herstellung von formmassen daraus
DE69319434D1 (de) Verfahren zur herstellung von mikropartikeln in emulsionen durch modifizierung der chemischen zusammensetzung der dispersen phase nach emulgierung
RU94045798A (ru) Стереоизомеры итраконазола или саперконазола, способ их получения, их комплексы и способ получения, фармацевтическая композиция на их основе и ее получение, способ получения водных растворов с повышенной концентрацией итраконазола или саперконазола
DE153998T1 (de) Verbindungen mit entzuendungshemmender aktivitaet, hergestellt durch komplexierung mit beta-cyclodextrin und pharmazeutische zusammensetzungen welche diese enthalten.
DE68923727D1 (de) Verfahren zur Herstellung eines aktiven Matrixsubstrats.
DE68915636D1 (de) Verfahren zur Herstellung von gegossenen Folien aus Fluorpolymeren mit hoher Produktivität.
ATE147622T1 (de) Verfahren zur herstellung von in lösungsmitteln verdünnbaren mikroträgern
DE59303365D1 (de) Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
FI955424A0 (fi) Syklodekstriinien kanssa muodostettuja taksoli- ja taksoteeri- tai Taxus-uuteinkluusiokomplekseja ja niiden valmistus ja käyttö
ATE154614T1 (de) Heparinderivate und verfahren zu deren herstellung
DE69217999D1 (de) Kontinuierliches verfahren zur herstellung von 2,5-dihydrofuranen aus gamma,delta-epoxybutenen
ATE135017T1 (de) Einschlusskomplexe mit silybinin, ihre herstellung und pharmazeutische präparate, die diese enthalten
DE69707911D1 (de) Verfahren zur herstellung von dithiobis-alkanesulfonaten und phosphonaten
DE1493939A1 (de) Verfahren zur Herstellung eines Systems von amphoterischen Traegern
ATE193286T1 (de) 10- deacetylbaccatin iii und 10- deacetyl 14 beta hydroxybaccatin iii derivaten, verfahren zu deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
DE69524393D1 (de) Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen durch die Absetzung von Arzenei/Zyklodextrin Komplexe auf inerte oder aktive Kerne
Göthlin et al. Electron microscopic studies of cytoplasmic filaments and fibers in different cell types of fracture callus in the rat
EP0538189A3 (de) Verfahren zur Herstellung von Hydroxyphenylcarbonsäureestern
ATE79551T1 (de) Verfahren zur herstellung eines komplexierten arzneimittels.
ATE194167T1 (de) Ein prozess für die herstellung von faktor ix biologischen ursprungs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties